Home > Orexigen Therapeutics Salary

Orexigen Therapeutics Salary

  • 32
  • 87
  • 24
Orexigen Therapeutics average salary is $71,365, median salary is $71,365 with a salary range from $71,365 to $71,365.
Orexigen Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Orexigen Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Orexigen Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Manager-application Development 71,365-71,365 Richmond, VA, 23218 2013 Orexigen Therapeutics Manager-application Development Salaries (1)
Orexigen Therapeutics Richmond, VA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Orexigen Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Orexigen Therapeutics Jobs
See more Orexigen Therapeutics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Orexigen Therapeutics... Information
  • Orexigen Therapeutics, Inc
  • Industry: BioTech/Drugs
  • City: La Jolla CA, CA
  • OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach. OREXIGEN begins by selecting a series of molecules with the desired pharmacology, and then screens them with a proprietary method for evidence of synergistic benefits. The best performing ¡°pairs¡± are advanced into the clinic. This business model has the potential to decrease the risk, time and cost for product development. An additional advantage of this approach is that it leverages established safety profiles of previously commercialized pharmaceutical components it uses in its combination regimens